SCHEMBL451379

SCHEMBL451379

C1=CNNc2c3c(ccc2=C1)=Nc1ccccc1-3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15068255 0.76
SCHEMBL11575107 0.74
SCHEMBL4499356 0.72
SCHEMBL9959991 0.70 IDO1 (0.39)
SCHEMBL4502527 0.68
SCHEMBL27987095 0.68 MAOB (0.31)
SCHEMBL17766690 0.65 GSK3A (0.36)
SCHEMBL4499833 0.65
SCHEMBL3835158 0.64
SCHEMBL19267584 0.63 ABCG2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260115305-A1 LINKERS, CONJUGATES AND APPLICATIONS THEREOF GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) 2026-04-30 US disclosed
US-20260077056-A1 LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) 2026-03-19 US disclosed
EP-4694935-A1 COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2026-02-18 EP disclosed
EP-4688871-A1 SITE-SPEICFIC ORTHOGONAL BIOCONJUGATE MODALITY AND APPLICATION THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2026-02-11 EP disclosed
US-12539336-B2 Antibody, linkers, payload, conjugates and applications thereof GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2026-02-03 US disclosed
EP-4683638-A1 COMBINATION OF ANTIBODY-DRUG CONJUGATE AND CANCER THERAPY, AND USE THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2026-01-28 EP disclosed
US-12467103-B2 Ligase fusion proteins and application thereof GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2025-11-11 US disclosed
EP-4601702-A1 LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2025-08-20 EP disclosed
WO-2022218331-A9 LINKERS, CONJUGATES AND APPLICATIONS THEREOF GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) 2025-06-19 WO disclosed
EP-4554956-A1 LINKERS, CONJUGATES AND APPLICATIONS THEREOF Genequantum Healthcare (Suzhou) Co., Ltd. (CN) 2025-05-21 EP disclosed
US-20060154944-A1 Novel tricyclic heterocycle compound ONO PHARMACEUTICAL CO., LTD. (JP) 2006-07-13 US disclosed
EP-1679309-A1 ANTISTRESS DRUG AND MEDICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
EP-1661881-A2 COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed
EP-1661879-A1 DIPHENYL ETHER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE ONO PHARMACEUTICAL CO., LTD. (JP) 2006-05-31 EP disclosed
EP-1637521-A1 NOVEL TRICYCLIC HETEROCYCLE COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2006-03-22 EP disclosed
US-4761411-A Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 US disclosed
US-4761411-A Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 US disclosed
US-4761411-A Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 US disclosed
EP-0129692-A2 Dibenzodiazepin derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-01-02 EP disclosed
EP-0129692-A2 Dibenzodiazepin derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-01-02 EP disclosed